The PRISMAP+ Consortium comprises 21 beneficiaries and 3 associated partners, featuring 10 radionuclide production infrastructures, 7 biomedical infrastructures, emerging infrastructures as well as top-level research centres, hospitals, the European Joint Research Centre and one SME.
The PRISMAP+ participants come from 14 different countries, namely Austria, Belgium, Denmark, France, Germany, Greece, Italy, Latvia, Norway, Portugal, Poland, Romania, Switzerland and the United Kingdom, under the coordination of CERN, the European Laboratory for Nuclear Research.